Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.685387
Title: The use of alginates and polyphenols in medicinal iron chelation for the improvement of colonic health
Author: Horniblow, Richard David
ISNI:       0000 0004 5914 827X
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2016
Availability of Full Text:
Access through EThOS:
Full text unavailable from EThOS. Thesis embargoed until 30 Sep 2020
Access through Institution:
Abstract:
Iron is central to the aetiology of gastrointestinal disease. Specifically, the toxic effects of excess, unabsorbed "luminal" iron ingested from the diet has been shown to be important in the development of inflammatory bowel disease and intestinal cancer. A platform for therapeutic intervention is likely to involve chelation of this luminal pool of iron. As such, a range of dietary iron chelators have been tested for their iron binding capacity. Natural biopolymers extracted from seaweed (alginates) and a variety of natural polyphenolic compounds were stratified in terms of their iron binding potential. One alginate, Manucol LD, was unique in its iron binding and demonstrated luminal iron chelation properties. With respect to the polyphenols, only one of the tested compounds (quercetin) displayed iron chelation activity in vitro and was able to suppress cellular concentrations of reactive oxygen species acting as an antioxidant. As such, it has been demonstrated that a unique alginate, Manucol LD, is an excellent candidate for sequestering luminal iron present in the gastrointestinal tract. These results underpin the rationale in utilising these types of natural and safe bio-polymers for the prevention and treatment of gastrointestinal disease.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.685387  DOI: Not available
Keywords: RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Share: